Propel Bio Management »

Jasper Therapeuritc shares owned by Propel Bio Management

Quarter-by-quarter ownership of Jasper Therapeuritc (JSPR) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Jasper Therapeuritc

Tip: Access up to 7 years of quarterly data

All positions including Jasper Therapeuritc held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jasper Therapeuritc by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.4M 1.0M 2.38
2024-12-31 $428k 20k 21.38

More positions owned by Propel Bio Management

Plains Gp Holdings Lp-cl Ltd Partnr Int A (PAGP)
Achieve Life Sciences (ACHV)
Akero Therapeutics (AKRO)
Milestone Pharmaceuticals (MIST)
Applied Therapeutics (APLT)
Phathom Pharmaceuticals (PHAT)
Abeona Therapeutics Com New (ABEO)
Delcath Systems Com New (DCTH)
Celldex Therapeutics Com New (CLDX)
Tscan Therapeutics (TCRX)
Compass Pathways Sponsored Ads (CMPS)
Nektar Therapeutics Com New (NKTR)
Jasper Therapeutics Com New (JSPR)
Zevra Therapeutics Com New (ZVRA)
Miragen Therapeutics (VRDN)

View all positions for Propel Bio Management

Top funds holding Jasper Therapeuritc

Velan Capital Investment Management
Soleus Capital Management
Acorn Capital Advisors
Kingdon Capital Management
Rock Springs Capital Management
Carlyle
Woodline Partners
Vanguard Group
T. Rowe Price Investment Management
Propel Bio Management
Qiming U.S. Ventures Management
Morgan Stanley
Citadel Advisors
Sphera Funds Management
Simplify Asset Management

View all funds holding Jasper Therapeuritc